Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2019 Jun 19;18:107. doi: 10.1186/s12943-019-1034-y

Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway

Yu Yin 1,2,3,#, Lingfan Xu 1,2,#, Yan Chang 2,4, Tao Zeng 2,5, Xufeng Chen 2, Aifen Wang 2, Jeff Groth 2, Wen-Chi Foo 2, Chaozhao Liang 1,, Hailiang Hu 2,6,, Jiaoti Huang 2,6,7,
PMCID: PMC6582568  PMID: 31217018

Correction to: Mol Cancer

https://doi.org/10.1186/s12943-019-0941-2

Following publication of the original article [1], the authors reported that name that appeared in published online version is incorrect. Aifeng Wang should be Aifen Wang. Corrected name is provided in the author group section above.

Contributor Information

Chaozhao Liang, Email: liang_chaozhao@163.com.

Hailiang Hu, Email: hailiang.hu@duke.edu.

Jiaoti Huang, Email: jiaoti.huang@duke.edu.

Reference

  • 1.Yu Yin, Lingfan Xu, Yan Chang, Tao Zeng, Xufeng Chen, Aifen Wang, Jeff Groth, Wen-Chi Foo, Chaozhao Liang, Hailiang Hu and Jiaoti Huang. N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.2019.10.1186/s12943-019-0941-2 [DOI] [PMC free article] [PubMed]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES